Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy

Tobias Maurer, Michael Souvatzoglou, Hubert Kübler, Katharina Opercan, Stefan Schmidt, Ken Herrmann, Jens Stollfuss, Gregor Weirich, Bernhard Haller, Jürgen E. Gschwend, Markus Schwaiger, Bernd J. Krause, Uwe Treiber

Research output: Contribution to journalArticlepeer-review

76 Scopus citations

Abstract

Background: Current imaging techniques are of limited value for lymph node (LN) staging in bladder cancer (BCa) patients scheduled for radical cystectomy (RC). Objective: Evaluate the diagnostic efficacy of [11C]choline positron emission tomography in combination with computed tomography (PET/CT) for LN staging of patients with BCa scheduled for RC and compare that efficacy with the diagnostic efficacy of CT and the gold standard of histopathologic evaluation. Design, setting, and participants: From June 2004 to May 2007, 44 patients with localized BCa were staged with [11C]choline PET with low-dose CT for attenuation correction and simultaneous intravenous and rectal contrast-enhanced diagnostic CT before RC and pelvic lymph node dissection (PLND). LNs were dissected from the internal and external iliac arteries up to the origin of the inferior mesentery artery according to a template with 14 predefined anatomic fields. Intervention: Diagnostic [11C]choline PET/CT before RC and regional LN dissection. Measurements: Histopathologic findings of resected LN were correlated with the results of [11C]choline PET/CT and CT alone in a patient- and field-based manner. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of [11C]choline PET/CT and CT were assessed. Results and limitations: LN metastases were found in 12 of 44 patients (27%). On patient-based analysis, sensitivity, specificity, PPV, NPV, and accuracy for [11C]choline PET/CT were calculated as 58%, 66%, 39%, 81%, and 64%, respectively; and for CT the calculated percentages were 75%, 56%, 39%, 86%, and 61%, respectively. Twenty-five of 471 dissected LN fields (5%) showed metastases. On field-based analysis, sensitivity, specificity, PPV, NPV, and accuracy for [11C]choline PET/CT were 28%, 95%, 21%, 96%, and 91%, respectively; for CT, the calculated percentages were 39%, 92%, 20%, 96%, and 90%, respectively. Limitations of this study are small patient number and the fact that not all patients underwent extensive PLND. Conclusions: In patients with BCa who were scheduled for RC, preoperative LN staging with [11C]choline PET/CT was not able to improve diagnostic efficacy compared with conventional CT alone.

Original languageEnglish
Pages (from-to)1031-1038
Number of pages8
JournalEuropean Urology
Volume61
Issue number5
DOIs
StatePublished - May 2012
Externally publishedYes

Keywords

  • Bladder cancer
  • Choline
  • Cystectomy
  • Lymph node
  • PET/CT
  • Staging

Fingerprint

Dive into the research topics of 'Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy'. Together they form a unique fingerprint.

Cite this